🇦🇺 Australia Country × Condition
melanoma Clinical Trials in Australia
Active clinical trials for melanoma with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1, Phase 2, Phase 2 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇦🇺 Australia
Active Trials in Australia (5)
NCT06536257
Recruiting
Personalised Immunotherapy Platform
Enrollment
1,000 pts
Country
🇦🇺 Australia
Melanoma Institute Australia
View Trial → NCT05180942
Recruiting
Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS
Enrollment
130 pts
Country
🇦🇺 Australia
Monash University
View Trial → NCT06060613 Phase 1, Phase 2
Recruiting
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Enrollment
208 pts
Country
🇦🇺 Australia
Obsidian Therapeutics, Inc.
View Trial → NCT05280314 Phase 2
Recruiting
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
Enrollment
60 pts
Country
🇦🇺 Australia
IO Biotech
View Trial → NCT05538130 Phase 1
Recruiting
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Enrollment
124 pts
Country
🇦🇺 Australia
Pfizer
View Trial → Frequently Asked Questions
How many melanoma clinical trials are active in Australia?
There are currently 5 active clinical trials for melanoma with sites in Australia, of which 5 are actively recruiting patients.
How can I join a melanoma clinical trial in Australia?
To join a melanoma clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are melanoma trials in Australia?
Active melanoma trials in Australia span Phase 1, Phase 2, Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology